Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 12 Sep 2024

Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy

in Cancer Immunity and Immunotherapy

Meng Su
Luoquan Chen
Li Xie
Aurore Fleurie
Renaud Jonquieres
Qing Cao
Benshang Li
Ji Liang
Yanjing Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450173

1,651 views
1 citation

Original Research

Published on 12 Sep 2024

Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy

in Cancer Immunity and Immunotherapy

Lexin Wang
Xue Zhou
Haisheng Yan
Yaping Miao
Binbin Wang
Yuheng Gu
Weining Fan
Ke Xu
Shangke Huang
Jie Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460308

1,928 views
2 citations

Brief Research Report

Published on 11 Sep 2024

Lighting the way: an economical alternative to feeder cell irradiation for T-cell expansion

in Cancer Immunity and Immunotherapy

Michael Benavidez Arias
An Nguyen
Daniel Ross
David Eagerton
Krit Ritthipichai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1453740

1,849 views

Original Research

Published on 11 Sep 2024

Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma

in Cancer Immunity and Immunotherapy

Jiatong Li
Yang Bai
He Zhang
Ting Chen
Guanning Shang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445555

3,688 views
1 citation

Original Research

Published on 11 Sep 2024

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

in Cancer Immunity and Immunotherapy

Xiaodong Niu
Tao Chang
Yuekang Zhang
Yanhui Liu
Yuan Yang
Qing Mao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447879

1,390 views

Mini Review

Published on 10 Sep 2024

Small molecule innate immune modulators in cancer therapy

in Cancer Immunity and Immunotherapy

Avijit Goswami
Sandeep Goyal
Princy Khurana
Kawaljit Singh
Barnali Deb
Aditya Kulkarni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395655

2,486 views
2 citations

Original Research

Published on 09 Sep 2024

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma

in Cancer Immunity and Immunotherapy

Irina Larionova
Pavel Iamshchikov
Anna Kazakova
Militsa Rakina
Maxim Menyalo
Kadriia Enikeeva
Guzel Rafikova
Yuliya Sharifyanova
Valentin Pavlov
Alisa Villert

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414716

3,117 views
1 citation

Original Research

Published on 09 Sep 2024

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

in Cancer Immunity and Immunotherapy

Ningning Lu
Shugui Sheng
Yiqi Xiong
Chuanren Zhao
Wenying Qiao
Xiaoyan Ding
Jinglong Chen
Yonghong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459740

1,970 views

Mini Review

Published on 09 Sep 2024

The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

in Cancer Immunity and Immunotherapy

Yongmei Wang
Saisai Li
Wenqin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436174

1,792 views

Original Research

Published on 09 Sep 2024

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States

in Cancer Immunity and Immunotherapy

Andong Li
Meiyu Wu
Ouyang Xie
Heng Xiang
Kehui Meng
Chongqing Tan
Long Wang
Xiaomin Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464092

2,213 views
3 citations

Review

Published on 09 Sep 2024

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

in Cancer Immunity and Immunotherapy

Beibei Liu
Ling Liu
Yang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450487

3,344 views
2 citations

Brief Research Report

Published on 09 Sep 2024

Differential regulation of heparan sulfate biosynthesis in fibroblasts cocultured with normal vs. cancerous prostate cells

in Cancer Immunity and Immunotherapy

Elvira V. Grigorieva
Anastasia V. Strokotova
Ingemar Ernberg
Vladimir I. Kashuba

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440623

1,509 views

Original Research

Published on 09 Sep 2024

The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach

in Cancer Immunity and Immunotherapy

Jie Min
Fei Dong
Yongyuan Chen
Wenshan Li
Yimin Wu
Yanbin Tan
Fan Yang
Pin Wu
Ying Chai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379812

1,460 views
1 citation

Correction

Published on 09 Sep 2024

Corrigendum: Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Martin Mucha
Martin Štach
Iva Kaštánková
Jana Rychlá
Jan Vydra
Petr Lesný
Pavel Otáhal

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483043

714 views
1 citation

Review

Published on 06 Sep 2024

Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19

in Cancer Immunity and Immunotherapy

Qiaoyan Si
Mingjian Bai
Xiaolong Wang
Tianyu Wang
Yan Qin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420463

1,812 views

Original Research

Published on 06 Sep 2024

Immunological signatures from irradiated cancer-associated fibroblasts

in Cancer Immunity and Immunotherapy

Rodrigo Berzaghi
Kristian Gundersen
Brede Dille Pedersen
Amalie Utne
Nannan Yang
Turid Hellevik
Inigo Martinez-Zubiaurre

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433237

2,359 views
1 citation

Navigation group

Articles

Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy

Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy

Lighting the way: an economical alternative to feeder cell irradiation for T-cell expansion

Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

Small molecule innate immune modulators in cancer therapy

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

Differential regulation of heparan sulfate biosynthesis in fibroblasts cocultured with normal vs. cancerous prostate cells

The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach

Corrigendum: Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19

Immunological signatures from irradiated cancer-associated fibroblasts